Characteristics and Outcomes Among Heart Failure Patients With Anemia and Renal Insufficiency With and Without Blood Transfusions (Public Discharge Data from California 2000–2006)

      Renal insufficiency and anemia are increasingly recognized as predictors of adverse events in heart failure. The impact of blood transfusion on mortality in patients with heart failure has not been previously characterized. We examined temporal changes in admissions and in-hospital mortality using public discharge data from California (2000 to 2006) and then evaluated the impact of renal insufficiency, anemia, and transfusion on in-hospital mortality in univariate and multivariate analyses. In total 596,456 unique patient admissions for heart failure were recorded. Renal insufficiency and anemia were common co-morbidities (27.4% and 27.1%, respectively) and 6.2% of patients received a transfusion of red blood cells. Renal insufficiency and anemia were associated with increased mortality (unadjusted odds ratio [OR] 2.45, 95% confidence interval [CI] 2.39 to 2.52, and 1.27, 95% CI 1.24 to 1.30, respectively). After adjustment, renal insufficiency (OR 2.54, 95% CI 2.46 to 2.62) and anemia (OR 1.12 95% CI 1.07 to 1.17) remained significant; however, transfusion emerged as the strongest single predictor (OR 3.81, 95% CI 3.51 to 4.13) of mortality. In conclusion, these data suggest that anemia and renal insufficiency are independently associated with mortality in an unselected heart failure population. This is the first study to demonstrate that transfusion magnifies this effect and is associated with a particularly poor prognosis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Heart Association
        Heart Disease and Stroke Statistics—2010 Update.
        American Heart Association, Dallas, TX2010 (Accessed: February 26, 2010)
        • Kazory A.
        • Ross E.A.
        Anemia: the point of convergence or divergence for kidney disease and heart failure?.
        J Am Coll Cardiol. 2009; 53: 639-647
        • Ronco C.
        • Haapio M.
        • House A.A.
        • Anavekar N.
        • Bellomo R.
        Cardiorenal syndrome.
        J Am Coll Cardiol. 2008; 52: 1527-1539
        • Patel U.D.
        • Hernandez A.F.
        • Liang L.
        • Peterson E.D.
        • LaBresh K.A.
        • Yancy C.W.
        • Albert N.M.
        • Ellrodt G.
        • Fonarow G.C.
        Quality of care and outcomes among patients with heart failure and chronic kidney disease: a Get With the Guidelines–Heart Failure Program study.
        Am Heart J. 2008; 156: 674-681
        • Fonarow G.C.
        • Heywood J.T.
        • Heidenreich P.A.
        • Lopatin M.
        • Yancy C.W.
        • ADHERE Scientific Advisory Committee and Investigators
        Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).
        Am Heart J. 2007; 153: 1021-1028
        • Yancy C.W.
        • Lopatin M.
        • Stevenson L.W.
        • De Marco T.
        • Fonarow G.C.
        • ADHERE Scientific Advisory Committee and Investigators
        Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
        J Am Coll Cardiol. 2006; 47: 76-84
        • Young J.B.
        • Abraham W.T.
        • Albert N.M.
        • Gattis Stough W.
        • Gheorghiade M.
        • Greenberg B.H.
        • O'Connor C.M.
        • She L.
        • Sun J.L.
        • Yancy C.W.
        • Fonarow G.C.
        • OPTIMIZE-HF Investigators and Coordinators
        Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (Insight from the OPTIMIZE-HF Registry).
        Am J Cardiol. 2008; 101: 223-230
        • Abraham W.T.
        • Fonarow G.C.
        • Albert N.M.
        • Stough W.G.
        • Gheorghiade M.
        • Greenberg B.H.
        • O'Connor C.M.
        • Sun J.L.
        • Yancy C.W.
        • Young J.B.
        • OPTIMIZE-HF Investigators and Coordinators
        Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
        J Am Coll Cardiol. 2008; 29: 347-356
        • Herzog C.A.
        • Muster H.A.
        • Li S.
        • Collins A.J.
        Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population.
        J Card Fail. 2004; 10: 467-471
      1. California Census Data.
        (Accessed: February 13, 2010)
        • Garty M.
        • Cohen E.
        • Zuchenko A.
        • Behar S.
        • Boyko V.
        • Iakobishvili Z.
        • Mittelman M.
        • Battler A.
        • Shotan A.
        • Gottlieb S.
        • Caspi A.
        • Hasdai D.
        • Heart Failure Survey in ISrael (HFSIS) Investigators
        Blood transfusion for acute decompensated heart failure—friend or foe?.
        Am Heart J. 2009; 158: 653-658
        • Anker S.D.
        • Comin Colet J.
        • Filippatos G.
        • Willenheimer R.
        • Dickstein K.
        • Drexler H.
        • Lüscher T.F.
        • Bart B.
        • Banasiak W.
        • Niegowska J.
        • Kirwan B.A.
        • Mori C.
        • von Eisenhart Rothe B.
        • Pocock S.J.
        • Poole-Wilson P.A.
        • Ponikowski P.
        • FAIR-HF Trial Investigators
        Ferric carboxymaltose in patients with heart failure and iron deficiency.
        N Engl J Med. 2009; 361: 2436-2448
        • Unger E.F.
        • Thompson A.M.
        • Blank M.J.
        • Temple R.
        Erythropoiesis-stimulating agents—time for a reevaluation.
        N Engl J Med. 2010; 362: 189-192
        • Heywood J.T.
        • Fonarow G.C.
        • Costanzo M.R.
        • Mathur V.S.
        • Wigneswaran J.R.
        • Wynne J.
        • ADHERE Scientific Advisory Committee and Investigators
        High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database.
        J Card Fail. 2007; 13: 422-430
        • Adams Jr, K.F.
        • Fonarow G.C.
        • Emerman C.L.
        • LeJemtel T.H.
        • Costanzo M.R.
        • Abraham W.T.
        • Berkowitz R.L.
        • Galvao M.
        • Horton D.P.
        • ADHERE Scientific Advisory Committee and Investigators
        Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).
        Am Heart J. 2005; 149: 209-216
        • Maluenda G.
        • Lemesle G.
        • Ben-Dor I.
        • Collins S.D.
        • Syed A.I.
        • Li Y.
        • Torguson R.
        • Kaneshige K.
        • Xue Z.
        • Suddath W.O.
        • Satler L.F.
        • Kent K.M.
        • Lindsay J.
        • Pichard A.D.
        • Waksman R.
        Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention.
        Am J Cardiol. 2009; 104: 1069-1073
        • Groenveld H.F.
        • Januzzi J.L.
        • Damman K.
        • van Wijngaarden J.
        • Hillege H.L.
        • van Veldhuisen D.J.
        • van der Meer P.
        Anemia and mortality in heart failure patients a systematic review and meta-analysis.
        J Am Coll Cardiol. 2008; 52: 818-827
        • Dunlay S.M.
        • Weston S.A.
        • Redfield M.M.
        • Killian J.M.
        • Roger V.L.
        Anemia and heart failure: a community study.
        Am J Med. 2008; 121: 726-732
        • Mitchell J.E.
        Emerging role of anemia in heart failure.
        Am J Cardiol. 2007; 99: 15D-20D
        • Horwich T.B.
        • Fonarow G.C.
        • Hamilton M.A.
        • MacLellan W.R.
        • Borenstein J.
        Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.
        J Am Coll Cardiol. 2002; 39: 1780-1786
        • Luthi J.C.
        • Flanders W.D.
        • Burnier M.
        • Burnand B.
        • McClellan W.M.
        Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients.
        BMC Nephrol. 2006; 7: 3
        • McClellan W.M.
        • Flanders W.D.
        • Langston R.D.
        • Jurkovitz C.
        • Presley R.
        Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population based study.
        J Am Soc Nephrol. 2002; 13: 1928-1936
        • Ezekowitz J.A.
        • McAlister F.A.
        • Armstrong P.W.
        Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.
        Circulation. 2003; 107: 223-225
        • Tang W.H.
        • Tong W.
        • Jain A.
        • Francis G.S.
        • Harris C.M.
        • Young J.B.
        Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure.
        J Am Coll Cardiol. 2008; 51: 569-576
        • Silverberg D.S.
        • Wexler D.
        • Blum M.
        • Sheps D.
        • Schwartz D.
        • Yachnin T.
        • Baruch R.
        • Tchebiner J.
        • Zubkov A.
        • Shaked M.
        • Steinbruch S.
        • Keren G.
        • Iaina A.
        Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
        Perit Dial Int. 2001; 21: S236-S240
        • Silverberg D.S.
        • Wexler D.
        • Blum M.
        • Tchebiner J.Z.
        • Sheps D.
        • Keren G.
        • Schwartz D.
        • Baruch R.
        • Yachnin T.
        • Shaked M.
        • Schwartz I.
        • Steinbruch S.
        • Iaina A.
        The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.
        Nephrol Dial Transplant. 2003; 18: 141-146
        • Besarab A.
        • Bolton W.K.
        • Browne J.K.
        • Egrie J.C.
        • Nissenson A.R.
        • Okamoto D.M.
        • Schwab S.J.
        • Goodkin D.A.
        The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
        N Engl J Med. 1998; 339: 584-590
        • Austin P.C.
        • Daly P.A.
        • Tu J.V.
        A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario.
        Am Heart J. 2002; 144: 290-296